Novo Nordisk A/S’s Wegovy pill was approved in the UK, opening up the obesity market to people who are wary of taking a shot.
The pill is authorized for adults with a body mass index of 30 or above, or who have a BMI of 27 to 30 with one other weight-related condition, the Medicines and Healthcare products Regulatory Agency said Thursday. The approval will allow the products to be sold to private patients and via telehealth providers, and Novo said it should be available within weeks.